Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nanoliposomal Irinotecan”

135 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 135 results

Large-scale testing (Phase 3)Study completedNCT03468335
What this trial is testing

2nd-line Therapy With Nal-IRI After Gem/Nab-pac in Advanced Pancreatic Cancer - Predictive Role of 1st-line Therapy

Who this might be right for
Locally Advanced Pancreatic CancerMetastatic Pancreatic Cancer
AIO-Studien-gGmbH 151
Testing effectiveness (Phase 2)Active Not RecruitingNCT05969899
What this trial is testing

Liposomal Irinotecan Based FOLFIRI With Bevacizumab in First-line Treatment of Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Fudan University 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06172036
What this trial is testing

Irinotecan Liposome for Resectable Pancreatic Cancer With or Without Addebelizumab

Who this might be right for
Neoadjuvant ChemotherapyResectable Pancreatic Cancer
Zhejiang University 180
Testing effectiveness (Phase 2)Study completedNCT03861702
What this trial is testing

Liposomal Irinotecan in Combination With Oxaliplatin, Leucovorin, and 5-fluorouracil for Patients With Locally Advanced Pancreatic Carcinoma:

Who this might be right for
Locally Advanced Pancreatic Carcinoma(LAPC)
Nelson Yee 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT04005339
What this trial is testing

NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer

Who this might be right for
Advanced Biliary Tract Cancer
Georgetown University 48
Testing effectiveness (Phase 2)Looking for participantsNCT06438822
What this trial is testing

Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil for Advanced Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
West China Hospital 51
Not applicableNot Yet RecruitingNCT06462105
What this trial is testing

Liposomal Irinotecan Combination Regimen for First-line Treatment of Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Zhou Chengzhi 60
Testing effectiveness (Phase 2)Ended earlyNCT05009953
What this trial is testing

Study of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract CancerIntrahepatic CholangiocarcinomaExtrahepatic Cholangiocarcinoma+1 more
CSPC Ouyi Pharmaceutical Co., Ltd. 17
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06434090
What this trial is testing

Liposomal Irinotecan Plus Bevacizumab in Irinotecan-refractory Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Sun Yat-sen University 74
Testing effectiveness (Phase 2)Looking for participantsNCT06643793
What this trial is testing

Evaluation of Irinotecan Liposome (II) Combined With 5-FU, LV, and Bevacizumab for mCRC

Who this might be right for
Colorectal Neoplasms Malignant
Affiliated Hospital of Nantong University 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07099794
What this trial is testing

A Randomized, Two-cohort, Prospective Phase II Clinical Study of the Second-line Treatment of Advanced Biliary System Tumors With Liposomal Irinotecan (II) Combination Regimen

Who this might be right for
Biliary Tract Cancer (BTC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 90
Testing effectiveness (Phase 2)Study completedNCT04662112
What this trial is testing

Liposomal Irinotecan, S-1, and Oxaliplatin in Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic CancerPancreatic Ductal Adenocarcinoma
Asan Medical Center 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06332950
What this trial is testing

Safety and Efficacy of Adebrelimab Plus Irinotecan Liposome (II) With or Without Famitinib in ES-SCLC Pre-treated With Immunotherapy

Who this might be right for
Extensive-stage Small-cell Lung Cancer
Baohui Han 80
Testing effectiveness (Phase 2)Study completedNCT04009876
What this trial is testing

Evaluate a Chemotherapy Treatment Followed by Chemo and Radiotherapy in Patients With Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer (LARC)
Fundación de investigación HM 30
Testing effectiveness (Phase 2)UnknownNCT05363007
What this trial is testing

Spleen Irradiation With Nanoliposomal Irinotecan Plus 5-FU and Leucovorin in Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Cancer
National Taiwan University Hospital 60
Testing effectiveness (Phase 2)Study completedNCT03712397
What this trial is testing

Nanoliposomal Irinotecan in Head & Neck and Esophagus After Prior Platinum-based Chemotherapy or Chemoradiotherapy

Who this might be right for
Head & Neck Cancer
National Health Research Institutes, Taiwan 59
Post-approval studies (Phase 4)Not Yet RecruitingNCT06499610
What this trial is testing

Clinical Study of Irinotecan Liposome Combination Therapy for Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
First Affiliated Hospital Xi'an Jiaotong University 44
Early research (Phase 1)Study completedNCT02022644
What this trial is testing

Study of Convection-Enhanced, Image-Assisted Delivery of Liposomal-Irinotecan In Recurrent High Grade Glioma

Who this might be right for
High Grade Glioma
University of California, San Francisco 18
Not applicableLooking for participantsNCT06361316
What this trial is testing

Irinotecan Liposome Combined With Oxaliplatin and Tegafur as Adjuvant Therapy for Pancreatic Cancer

Who this might be right for
Pancreatic CancerAdjuvant Therapy
Kuirong Jiang 53
Early research (Phase 1)Study completedNCT04088786
What this trial is testing

Phase I Trial HIPEC With Nal-irinotecan

Who this might be right for
Peritoneal CancerPseudomyxoma PeritoneiMucinous Adenocarcinoma+5 more
Stony Brook University 18
Load More Results